|
A Phase 2 Study of ET743 in Subjects With Advanced Liposarcoma or Leiomyosarcoma Clinical Trials Information presented on Clinical Trials Search is not designed to be a substitute for proven healthcare advice, travels to or treatment by using a genuine medical doctor. We are not physicians. Always confer with your doctor on A Phase 2 Study of ET743 in Subjects With Advanced Liposarcoma or Leiomyosarcoma conditions. Clinical Trials Search.org is a site devoted to listing clinical research studies in human subjects. A Phase 2 Study of ET743 in Subjects With Advanced Liposarcoma or Leiomyosarcoma Clinical research trials and A Phase 2 Study of ET743 in Subjects With Advanced Liposarcoma or Leiomyosarcoma healthcare trials take place in many of cities across the United States of America. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials generally evaluate the effectiveness of new drugs. The function of the studies / undertakings is to answer specific human medical questions. Clinical trials are a popular means for mDs, government agencies, and private sector companies to find treatments for all forms of conditions, including A Phase 2 Study of ET743 in Subjects With Advanced Liposarcoma or Leiomyosarcoma. A Phase 2 Study of ET743 in Subjects With Advanced Liposarcoma or Leiomyosarcoma Clinical Trials and other clinical trials allow for volunteers to access medical treatment alternatives before they are available to the masses. Many times the test subjects undergo treatment for without cost, and occasionally they are compensated for their time. Occasionally there is a cost for a A Phase 2 Study of ET743 in Subjects With Advanced Liposarcoma or Leiomyosarcoma clinical trial. Test subjects oftentimes recieve the best healthcare possible for their A Phase 2 Study of ET743 in Subjects With Advanced Liposarcoma or Leiomyosarcoma condition. Hazards are a reality, nonetheless, and might include additional or frequent doctor trips, healthcare hazards (perhaps life-jeopardizing), and/or the treatment being ineffective. Trials are federally regulated with rigid guidelines to protect clinical trials subjects.
|
|
|
|
|
|
|
Home > "A" Clinical Trials Conditions > A Phase 2 Study of ET743 in Subjects With Advanced Liposarcoma or Leiomyosarcoma  A Phase 2 Study of ET743 in Subjects With Advanced Liposarcoma or Leiomyosarcoma
A Phase 2 Study of ET743 in Subjects With Advanced Liposarcoma or Leiomyosarcoma
For Condition: Liposarcoma,Leiomyosarcoma
Status: Recruiting
Sponsor(s): Johnson & Johnson Pharmaceutical Research and Development, L.L.C. , PharmaMar
Synopsis: This is a study to test the safety and effectiveness of an investigational chemotherapy agent in subjects with advanced liposarcoma or leiomyosarcoma. Subjects who meet all entry criteria and have signed the informed consent will be enrolled in the study. Participants will be required to attend regular clinic visits to receive study medication and have their status monitored. They will also be required to have radiologic tumor assessments performed at multiple times throughout the study. A detailed explanation can be provided by the investigator conducting the study
Details:
Eligibility:
Study Type: Interventional, Treatment, Randomized, Open Label, Active Control, Parallel Assignment, Safety/Efficacy Study
Minimum Age/Maximum Age: 18 Years/
Genders: Both
Protocol Entry Criteria: - Male or female subjects 18 years of age or older - Advanced or metastatic liposarcoma or leiomyosarcoma - Pathology specimen available for centralized review - Relapsed or progressive disease - Prior treatment with anthracycline and ifosfamide - At least one measurable tumor leasion - Adequate bone marrow, liver and kidney function - ECOG performance status 0 or 1
Total Enrollment:
Location and Contact Information:
Mayo Clinic Comprehensive Cancer Center *Recruiting*
Rochester, Minnesota, 55905
United States
Recruiting Burg Candace 507-538-0152
UMDNJ Division of Med Onc/Hem *Recruiting*
Newark, New Jersey, 07103-2714
United States
Recruiting Anne Reinert 973-972-2163
Columbia Presbyterian Medical Center *Recruiting*
New York City, New York, 10032
United States
Recruiting Mary Keohan 212-305-0592
Dana-Faber Cancer Institute Ctr for Sarcoma and Bone Oncology/Adult Oncology *Recruiting*
Boston, Massachusetts, 02115
United States
Recruiting Myra Amand 617-632-3408
Washington Cancer Institute *Recruiting*
Washington D.C., District of Columbia, 20010
United States
Recruiting Damian Reeder 202-877-9374
University of Minnesota Division of Medical Oncology *Recruiting*
Minneapolis, Minnesota, MN 55455
United States
Recruiting Katie Mellskog 612-624-6490
University of Colorado Cancer Center *Recruiting*
Aurora, Colorado, 80045
United States
Recruiting Carol Mangold 720-848-0664
University of Michigan Cancer Ctr *Recruiting*
Ann Arbor, Michigan, 48109-0948
United States
Recruiting Denise Reinke 734-936-4188
Seattle Cancer Care Alliance *Recruiting*
Seattle, Washington, 98109-1023
United States
Recruiting Teri Lewan 206-667-1922
The Cleveland Clinic Foundation Department of Hem/Onc *Recruiting*
Cleveland, Ohio, 44195
United States
Recruiting Melissa Kadar 216-444-6839
Vanderbilt University SOM *Recruiting*
Nashville, Tennessee, 37232-5536
United States
Recruiting Peggy Krozely 615-936-1163
Oncology Specialists *Recruiting*
Park Ridge, Illinois, 60068
United States
Recruiting Laura Walsh 847-723-8254
University of Indiana Cancer Center *Recruiting*
Indianapolis, Indiana, 46260
United States
Recruiting Sandy Staehler 317-274-3515
Fox Chase Cancer Centre *Recruiting*
Philadelphia, Pennsylvania, 19111-2412
United States
Recruiting Monica Davey 215-728-5534
Norton Hospital Inc. *Recruiting*
Louisville, Kentucky, 40202
United States
Recruiting Kelly Carron 502-629-3498
Huntsman Cancer Institute, University of Utah *Recruiting*
Salt Lake City, Utah, 84112-5550
United States
Recruiting Connie Skliar 801-585-5162
Sant P. Chawla, M.D., Inc. *Recruiting*
Los Angeles, California, 90067
United States
Recruiting Victoria Chua 310-556-8015
Medical College of Wisconsin, Dept. of Neoplastic Diseases *Recruiting*
Milwaukee, Wisconsin, 53226
United States
Recruiting Debra Pastorek 414-805-6837
Additional Information:
Study ID Numbers: ET743-STS-201;
Study Start Date: April 2003
Record last reviewed: April 2004
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00060944
Other Leiomyosarcoma Studies:
1. A Phase 2 Study of ET743 in Subjects With Advanced Liposarcoma or Leiomyosarcoma
Related Studies:
Other Leiomyosarcoma Clinical Trials
Other Tennessee Clinical Trials
Other Nashville Clinical Trials
A Phase 2 Study of ET743 in Subjects With Advanced Liposarcoma or Leiomyosarcoma
|
|
|
|
|
|
|
|
